NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

The impact of delay in cryo-fixation on biomarkers of Src tyrosine kinase activity in human breast and bladder cancers.

Author(s): Jones RJ, Boyce T, Fennell M, Jacobs V, Pinto F, Duffield E, Clack G, Green T, Kelly J, Robertson J

Publication: Cancer Chemother Pharmacol, 2008, Vol. 61, Page 23-32

PubMed ID: 17909809 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine if prolonged cold ischemia prior to cryopreservation of bladder and breast cancer specimens alters levels of phospho-Paxillin, phospho-focal adhesion kinase (FAK), or total phospho-Tyrosine.

Conclusion of Paper

Significant effects on phosphorylated protein levels were limited to the longest cold ischemia time investigated (60 min) and included a significant and robust increase in phospho-Paxillin, total phospho-Tyrosine, and the ratio of phospho-Paxillin to total Paxillin. Although significant effects were only reported among breast specimens it is unclear if effects are tissue-specific, as the 60 min timepoint was not investigated among bladder carcinoma specimens.

Studies

  1. Study Purpose

    The purpose of this study was to determine if prolonged cold ischemia of breast biopsy specimens altered levels of the following established Src kinase targets: phospho-Paxillin, phospho-FAK and total phospho-Tyrosine, as well as the ratio of phospho-Paxillin to total Paxillin. Specimens were stored at room temperature on damp blotting paper prior to cryopreservation by immersion on liquid nitrogen. Although breast biopsy specimens were collected from a total of 20 patients, the sample size for each timepoint ranged from 3 to 10 patients.

    Summary of Findings:

    Significant increases in the levels of phospho-Paxillin (100%) and total phospho-Tyrosine (350%), as well as the ratio of phospho-Paxillin to total Paxillin were observed in breast biopsy specimens after a cold ischemia time of 60 min compared to 0 min controls. Minute fluctuations in total Paxillin, and phospho-FAK levels after cold ischemia of 60 min were nonsignificant. Cold ischemia of less than 60 min did not affect any of the phospho-proteins analyzed.

    Biospecimens
    Preservative Types
    • Frozen
    Diagnoses:
    • Neoplastic - Carcinoma
    Platform:
    AnalyteTechnology Platform
    Protein Immunoassay
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Acquisition Cold ischemia time 0 min
    10 min
    20 min
    30 min
    45 min
    60 min
    Immunoassay Specific Targeted peptide/protein Paxillin
    Phospho-Paxillin
    Phospho-FAK
    Total phospho-Tyrosine
  2. Study Purpose

    The purpose of this study was to determine if prolonged cold ischemia of surgically resected bladder specimens altered levels of the following established Src kinase targets: phospho-Paxillin, phospho-FAK and total phospho-Tyrosine, as well as the ratio of phospho-Paxillin to total Paxillin. Specimens were stored at room temperature in normal saline prior to cryopreservation by immersion in liquid nitrogen. Although bladder specimens were collected from a total of 5 patients, the sample size for each timepoint ranged from 4 to 5 patients.

    Summary of Findings:

    Bladder specimens subjected to cold ischemia at room temperature in normal saline for up to 45 min did not exhibit any significant or robust changes in expression of phospho- or total Paxillin, phospho-FAK, or total phospho-Tyrosine.

    Biospecimens
    Preservative Types
    • Frozen
    Diagnoses:
    • Neoplastic - Carcinoma
    Platform:
    AnalyteTechnology Platform
    Protein Immunoassay
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Acquisition Cold ischemia time 0 min
    10 min
    20 min
    30 min
    45 min
    Immunoassay Specific Targeted peptide/protein Paxillin
    phospho-Paxillin
    phospho-FAK
    Total phospho-Tyrosine

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...